MVM. A. Vokuev

M. A. Vokuev

*This is an algorithmically generated author record based on publicly available information.

M. A. Vokuev has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Automated non-invasive assessment of tear film break-up time in patients with open-angle glaucoma on antihypertensive therapy and in patients with newly diagnosed glaucoma after SLT

    by S. Yu. Anisimova, S. I. Anisimov, O. B. Kochmala, Peng Ling, N. A. Gavrilova, M. A. Vokuev

    PURPOSE. To evaluate the potential of corneal topography analysis in assessment of the precorneal tear film stability.METHODS. The study included two groups of randomly selected participants: patients receiving topical hypotensive therapy, and patients with newly diagnosed primary open-angle glaucoma (POAG) who had underwent selective laser trabeculoplasty (SLT). All study participants underwent measurement of tear break-up time (TBUT) and meibomian gland dysfunction. The CSO Sirius+ topographer with software designed for diagnosing dry eye syndrome was used.RESULTS. Patients who had been on topical therapy for various durations (ranging from 3 months to 10 years) demonstrated significant evidence of reduced TBUT, indicating the presence of dry eye syndrome. In contrast, patients who underwent SLT without receiving medication had TBUT values within normal limits.CONCLUSION. Preliminary results of this comparative study on the use of corneal topography used for diagnosing dry eye syndrome in evaluation of tear film stability demonstrated the informative value and advantages of this method compared to conventional techniques (Schirmer’s test, Norn’s test).

  • Open Access

    Comparative outcomes of topical and laser treatment in newly diagnosed patients with primary glaucoma

    by S. Yu. Anisimova, S. I. Anisimov, O. B. Kochmala, Peng Ling, M. A. Vokuev, N. A. Gavrilova

    PURPOSE. To conduct a comparative evaluation of the efficacy and safety of medication-based hypotensive therapy versus selective laser trabeculoplasty (SLT) in patients with newly diagnosed primary open-angle glaucoma (POAG).METHODS. The study included 59 patients with POAG (59 eyes), divided into two groups. Group 1 received monotherapy with tafluprost, while Group 2 underwent SLT. In cases of intraocular pressure (IOP) decompensation during the follow-up period, Group 1 was prescribed additional topical therapy or switched to SLT, and Group 2 was started on topical therapy. The follow-up lasted 6 months. The study assessed the hypotensive efficacy of the treatments and the condition of visual functions.RESULTS. By the end of the observation period, the hypotensive efficacy in Group 1 was 24%, with an IOP level of 20.1±1.6 mm Hg. Some adverse effects related to topical therapy were observed. In Group 2, the hypotensive efficacy was 20.5%, with an average IOP level of 16.8±2.0 mm Hg. No adverse events were reported in Group 2.CONCLUSION. Preliminary outcomes indicate that the hypotensive efficacy of monotherapy with prostaglandin analogues and SLT is comparable. The clear advantages of laser treatment include reduced adverse effects, which promotes better compliance, adherence to treatment, and decreased risk of disease progression.